Richard Bucala

2.8k total citations
21 papers, 2.3k citations indexed

About

Richard Bucala is a scholar working on Clinical Biochemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Richard Bucala has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Clinical Biochemistry, 12 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Richard Bucala's work include Advanced Glycation End Products research (14 papers), Natural Antidiabetic Agents Studies (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Richard Bucala is often cited by papers focused on Advanced Glycation End Products research (14 papers), Natural Antidiabetic Agents Studies (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Richard Bucala collaborates with scholars based in United States, Japan and Germany. Richard Bucala's co-authors include Anthony Cerami, Zenji Makita, Helen Vlassara, Yousef Al‐Abed, Peter Model, Andrew T. Papoulis, Jason Chesney, Peter Ulrich, Anthony Cerami and Sara Vasan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Richard Bucala

21 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Bucala United States 17 1.3k 728 728 384 264 21 2.3k
Harold F. Sims United States 35 839 0.7× 2.3k 3.1× 501 0.7× 794 2.1× 277 1.0× 62 3.8k
Qida Ju United States 12 387 0.3× 988 1.4× 352 0.5× 425 1.1× 55 0.2× 16 2.0k
Robert Rognstad United States 30 642 0.5× 1.5k 2.1× 532 0.7× 985 2.6× 300 1.1× 75 2.9k
I.T. Oliver Australia 22 445 0.4× 911 1.3× 331 0.5× 439 1.1× 89 0.3× 55 2.2k
Simone Denis Netherlands 37 1.1k 0.9× 2.5k 3.5× 110 0.2× 650 1.7× 547 2.1× 80 3.6k
James Ashmore United States 30 366 0.3× 1.5k 2.0× 802 1.1× 993 2.6× 382 1.4× 128 3.3k
Skaidrite K. Krisans United States 32 520 0.4× 2.6k 3.5× 150 0.2× 445 1.2× 403 1.5× 51 3.4k
U. Karbach Germany 20 198 0.2× 521 0.7× 110 0.2× 139 0.4× 180 0.7× 45 2.0k
Rob Ofman Netherlands 28 714 0.6× 1.8k 2.4× 127 0.2× 467 1.2× 201 0.8× 64 2.2k
Samar M. Hammad United States 28 125 0.1× 1.4k 2.0× 245 0.3× 471 1.2× 122 0.5× 66 2.6k

Countries citing papers authored by Richard Bucala

Since Specialization
Citations

This map shows the geographic impact of Richard Bucala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bucala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bucala more than expected).

Fields of papers citing papers by Richard Bucala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Bucala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bucala. The network helps show where Richard Bucala may publish in the future.

Co-authorship network of co-authors of Richard Bucala

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Bucala. A scholar is included among the top collaborators of Richard Bucala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Bucala. Richard Bucala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Telang, Sucheta, Brian F. Clem, Alden C. Klarer, et al.. (2012). Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation. Journal of Translational Medicine. 10(1). 95–95. 76 indexed citations
2.
Atsumi, Toshiya, Jun Takeuchi, Hidenori Bando, et al.. (2005). Expression of Inducible 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase/PFKFB3 Isoforms in Adipocytes and Their Potential Role in Glycolytic Regulation. Diabetes. 54(12). 3349–3357. 63 indexed citations
3.
Bucala, Richard. (2002). New horizons in AGE research. International Congress Series. 1245. 113–117. 2 indexed citations
4.
Ferguson, Gail P., Sonya VanPatten, Richard Bucala, & Yousef Al‐Abed. (1999). Detoxification of Methylglyoxal by the Nucleophilic Bidentate, Phenylacylthiazolium Bromide. Chemical Research in Toxicology. 12(7). 617–622. 14 indexed citations
5.
Chesney, Jason, Robert O. Mitchell, Fabio Benigni, et al.. (1999). An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: Role in tumor cell glycolysis and the Warburg effect. Proceedings of the National Academy of Sciences. 96(6). 3047–3052. 236 indexed citations
6.
Al‐Abed, Yousef, Erwin Schleicher, Wolfgang Voelter, et al.. (1998). Identification of N2-(1-carboxymethyl)guanine (CMG) as a guanine advanced glycation end product. Bioorganic & Medicinal Chemistry Letters. 8(16). 2109–2110. 7 indexed citations
7.
Wang, Xingyu, Richard Bucala, & Ross W. Milne. (1998). Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products. Proceedings of the National Academy of Sciences. 95(13). 7643–7647. 28 indexed citations
8.
Fishbane, Steven, Richard Bucala, Brian J.G. Pereira, Hank Founds, & Helen Vlassara. (1997). Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia. Kidney International. 52(6). 1645–1650. 27 indexed citations
9.
Al‐Abed, Yousef & Richard Bucala. (1997). Efficient Scavenging of Fatty Acid Oxidation Products by Aminoguanidine. Chemical Research in Toxicology. 10(8). 875–879. 35 indexed citations
10.
Al‐Abed, Yousef, Tomoko Mitsuhashi, Peter Ulrich, & Richard Bucala. (1996). Novel modifications of Nα-boc-arginine and Nα-CBZ-lysine by methylglyoxal. Bioorganic & Medicinal Chemistry Letters. 6(13). 1577–1578. 17 indexed citations
11.
Vasan, Sara, Xin Zhang, Xini Zhang, et al.. (1996). An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature. 382(6588). 275–278. 385 indexed citations
12.
Papoulis, Andrew T., Yousef Al‐Abed, & Richard Bucala. (1995). Identification of N2-(1-Carboxyethyl)guanine (CEG) as a Guanine Advanced Glycosylation End Product. Biochemistry. 34(2). 648–655. 138 indexed citations
13.
Nishino, Toshihiko, Yasuhiro Horii, Hideo Shiiki, et al.. (1995). Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy. Human Pathology. 26(3). 308–313. 48 indexed citations
14.
Al‐Abed, Yousef & Richard Bucala. (1995). Nε-carboxymethyllysine formation by direct addition of glyoxal to lysine during the Maillard reaction. Bioorganic & Medicinal Chemistry Letters. 5(18). 2161–2162. 22 indexed citations
15.
Bucala, Richard & Anthony Cerami. (1992). Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging. Advances in pharmacology. 23. 1–34. 439 indexed citations
16.
Makita, Zenji, Helen Vlassara, Anthony Cerami, & Richard Bucala. (1992). Immunochemical detection of advanced glycosylation end products in vivo.. Journal of Biological Chemistry. 267(8). 5133–5138. 442 indexed citations
17.
Bucala, Richard, Peter Ulrich, Brian T. Chait, F. Aladar Bencsath, & Anthony Cerami. (1986). Structure of lysine adducts with 16α-hydroxyestrone and cortisol. Journal of Steroid Biochemistry. 25(1). 127–133. 13 indexed citations
18.
Bucala, Richard, Shigeo Manabe, R Urban, & Anthony Cerami. (1985). Nonenzymatic modification of lens crystallins by prednisolone induces sulfhydryl oxidation and aggregate formation: In vitro and in vivo studies. Experimental Eye Research. 41(3). 353–363. 36 indexed citations
19.
Bucala, Richard, Jack Fishman, & Anthony Cerami. (1984). The reaction of 16alpha-hydroxyestrone with erythrocytes in vitro and in vivo. European Journal of Biochemistry. 140(3). 593–598. 31 indexed citations
20.
Bucala, Richard, Peter Model, & Anthony Cerami. (1984). Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression.. Proceedings of the National Academy of Sciences. 81(1). 105–109. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harold F. Sims Breakdown of academic impact, for papers by Qida Ju Breakdown of academic impact, for papers by Robert Rognstad Breakdown of academic impact, for papers by I.T. Oliver Breakdown of academic impact, for papers by Simone Denis Breakdown of academic impact, for papers by James Ashmore Breakdown of academic impact, for papers by Skaidrite K. Krisans Breakdown of academic impact, for papers by U. Karbach Breakdown of academic impact, for papers by Rob Ofman Breakdown of academic impact, for papers by Samar M. Hammad
Rankless by CCL
2026